Bruker Corporation Cash Flow Conversion Efficiency
Bruker Corporation cash flow conversion efficiency. Based on the latest financial reports, Bruker Corporation (BRKR) has a cash flow conversion efficiency ratio of 0.092x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($229.80 Million) by net assets ($2.51 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Bruker Corporation (1999–2025)
Cash flow conversion efficiency of Bruker Corporation from 1999 to 2025. This chart illustrates how Bruker Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Bruker Corporation (BRKR) stock price for real-time trading data and today's change.
Bruker Corporation Cash Flow Conversion Ratio Explained
Bruker Corporation cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Bruker Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bruker Corporation ranked by their cash flow conversion efficiency. Also see Bruker Corporation (BRKR) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Walsin Technology Corp
TW:2492
|
0.013x |
|
MGIC Investment Corp
NYSE:MTG
|
0.037x |
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
-0.183x |
|
Marfrig Global Foods S.A.
SA:MRFG3
|
0.234x |
|
UL Solutions Inc.
NYSE:ULS
|
0.164x |
|
Vietnam Technological And Commercial Joint Stock Bank
VN:TCB
|
-0.024x |
|
Loar Holdings Inc.
NYSE:LOAR
|
0.022x |
|
Localiza Rent a Car S.A
SA:RENT3
|
-0.049x |
Annual Cash Flow Conversion Efficiency for Bruker Corporation (1999–2025)
The table below shows the annual cash flow conversion efficiency of Bruker Corporation from 1999 to 2025. Review Bruker Corporation free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.51 Billion | $134.10 Million | 0.053x | -61.41% |
| 2024-12-31 | $1.82 Billion | $251.30 Million | 0.138x | -44.11% |
| 2023-12-31 | $1.41 Billion | $350.10 Million | 0.248x | +7.01% |
| 2022-12-31 | $1.13 Billion | $262.00 Million | 0.231x | -11.08% |
| 2021-12-31 | $1.08 Billion | $282.40 Million | 0.260x | -23.88% |
| 2020-12-31 | $974.30 Million | $333.20 Million | 0.342x | +50.35% |
| 2019-12-31 | $938.20 Million | $213.40 Million | 0.227x | -14.11% |
| 2018-12-31 | $905.10 Million | $239.70 Million | 0.265x | +25.81% |
| 2017-12-31 | $733.50 Million | $154.40 Million | 0.210x | +11.54% |
| 2016-12-31 | $693.10 Million | $130.80 Million | 0.189x | -39.65% |
| 2015-12-31 | $732.90 Million | $229.20 Million | 0.313x | +111.14% |
| 2014-12-31 | $771.70 Million | $114.30 Million | 0.148x | -13.15% |
| 2013-12-31 | $850.20 Million | $145.00 Million | 0.171x | -9.08% |
| 2012-12-31 | $709.60 Million | $133.10 Million | 0.188x | +33.65% |
| 2011-12-31 | $624.90 Million | $87.70 Million | 0.140x | -52.58% |
| 2010-12-31 | $527.40 Million | $156.10 Million | 0.296x | -17.25% |
| 2009-12-31 | $418.80 Million | $149.80 Million | 0.358x | +4.63% |
| 2008-12-31 | $312.70 Million | $106.90 Million | 0.342x | +214.12% |
| 2007-12-31 | $259.20 Million | $28.21 Million | 0.109x | -44.65% |
| 2006-12-31 | $191.71 Million | $37.69 Million | 0.197x | -3.06% |
| 2005-12-31 | $208.03 Million | $42.19 Million | 0.203x | +5061.32% |
| 2004-12-31 | $217.47 Million | $-889.00K | -0.004x | +86.39% |
| 2003-12-31 | $202.55 Million | $-6.08 Million | -0.030x | +66.67% |
| 2002-12-31 | $126.38 Million | $-11.39 Million | -0.090x | -0.18% |
| 2001-12-31 | $127.55 Million | $-11.47 Million | -0.090x | -5430.38% |
| 2000-12-31 | $124.17 Million | $-202.00K | -0.002x | -100.30% |
| 1999-12-31 | $10.06 Million | $5.44 Million | 0.541x | -- |
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, ser… Read more